Search

Your search keyword '"Ruscitti, Piero"' showing total 856 results

Search Constraints

Start Over You searched for: Author "Ruscitti, Piero" Remove constraint Author: "Ruscitti, Piero"
856 results on '"Ruscitti, Piero"'

Search Results

1. The Evaluation of Effectiveness and Safety of Guselkumab in Patients with Psoriatic Arthritis in a Prospective Multicentre “Real-Life” Cohort Study

3. Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study

5. Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry

7. Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry

8. Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry

9. Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry

12. Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus

13. Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry

14. The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study

16. Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry

17. COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity

18. Musculoskeletal manifestations in children with Behçet’s syndrome: data from the AIDA Network Behçet’s Syndrome Registry

19. Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase

21. Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission

23. Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort

27. Development and implementation of the AIDA International Registry for patients with Behçet’s disease

28. List of contributors

30. The administration of methotrexate in patients with Still's disease, “real-life” findings from AIDA Network Still Disease Registry

31. Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases

35. Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Uveitis

36. Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis

37. Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study

38. Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis

40. Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registries

41. Short-term effectiveness of guselkumab in psoriatic arthritis patients and suggestive features of axial involvement: results from a real-life multicentre cohort

43. Early psoriatic arthritis: clinical and therapeutic challenges

45. The Systemic Score May Identify Life‐Threatening Evolution in Still Disease: Data from the GIRRCS AOSD‐Study Group and the AIDA Network Still Disease Registry.

46. Retention Rate of Ixekizumab in Psoriatic Arthritis: A Real-World Study.

48. Systematic review and meta-analysis of pharmacological interventions in adult-onset Still's disease highlights the beneficial role of biologic DMARDs

50. Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry

Catalog

Books, media, physical & digital resources